Illinois’ bioscience industry is an innovative and growing component of the overall U.S. economy. With a track record of generating high-quality jobs and steady growth, the bioscience industry has been a consistent engine for our economy and a key strength during past economic recessions. American innovation in bioscience helps support state and local communities in a variety of ways ranging from job creation, construction, tax revenues, and other economic impact values.

Driven by small-company innovators, the bioscience industry has also mobilized in an unprecedented manner to address the global COVID-19 pandemic, while continuing to develop other life-saving and life-enhancing products and services for the U.S. and the world. America’s bioscience industry as an innovator and economic driver has never been more important, both for our health and our economic stability.

Total Number of Facilities in Illinois 18
Jobs Directly Supported by the Industry in Illinois 90941
Annual Average Wage
$141681
Total Clinical Trials
1092
Dollar Amount Invested in Clinical Trials
$387.1 Million
Clinical Trial Participants
26741
Total Clinical Trial Economic Impact
$1.15 Billion

View Facilities By District

District Total Facilities in District View Facilities in District
IL01 1

The University of Chicago

IL05 2

AbbVie Inc.

NUAgo Therapeutics

IL06 1

Pharmazz Inc

IL07 7

ICEX Spain Trade & Investment

Illinois Biotechnology Innovation Organization (iBIO)

McDonnell Boehnen Hulbert & Berghoff LLP

Schedule 1 Therapeutics

SIWA Therapeutics, Inc.

Temprian Oncology, Inc.

University of Illinois System

IL09 4

2Blades

Angiotensin Therapeutics, Inc.

LanzaTech

Northwestern University

IL10 2

Endevica Bio

LanzaJet

IL13 1

National Corn-to-Ethanol Research Center (NCERC)